Phase 2 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 40 years old or older at the time of signing the consent form
• You have been diagnosed with idiopathic pulmonary fibrosis (IPF) — a condition where the lungs become scarred over time — within the last 5 years, according to recognised international guidelines
• Your diagnosis was confirmed through a specific type of lung scan (a high-resolution CT scan) and, if you had one, a surgical lung tissue sample
• You are in a stable condition and considered suitable to take part, based on your medical history, a physical check-up, and standard tests including blood tests and a heart trace (ECG)
• Your lungs can hold at least 45% of the air they normally should (confirmed by a breathing test)
• Your lungs' ability to transfer oxygen into the blood falls within a specific range — between 30% and 80% of what is considered normal (confirmed by a breathing test)
• If you are able to have children (male or female), you must be willing to use highly effective contraception for at least 90 days after your last dose of the study drug

Who may not be able to join:

• You are currently taking, or have taken within the last 3 months, the IPF medications nintedanib or pirfenidone by mouth — or you have previously taken both of these medications together
• A specific breathing test result (measuring how well air flows out of your lungs) shows a certain ratio that may indicate a different lung condition (confirm with trial site)
• You have a history of serious heart disease, significant bleeding problems, or significant liver or kidney disease (confirm with trial site for exact definitions)
• You have a history of a bowel condition called diverticular disease, or you have had abdominal surgery within the 4 weeks before the screening visit
• You have had cancer in the past 5 years (some exceptions may apply — confirm with trial site)
• You have smoked within the past 3 months, are unwilling to stop smoking during the study, or currently use illegal or misused drugs
• You are currently pregnant or breastfeeding
• You have taken part in another clinical trial or used any experimental drug (including for IPF) within the past 30 days before screening

Please note: this is not a complete list — additional eligibility criteria may apply.

Important: Always verify eligibility with the trial site directly before applying.